Finance

Lists
Why is GTBP up 12,27%?
Dive Deeper
GTBP:NASDAQ
GT Biopharma Inc
6,68 $
+12,27%
(+0,73) 1D
6,82 $
+2,12% (+0,14)
After hours
Closed: 9 қаз., 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for GTBP...
Open
5,96 $
High
6,68 $
Low
5,83 $
Mkt. cap
12,05 млн
Avg. vol.
217,08 м.
Volume
43,38 мың
52-wk high
28,75 $
52-wk low
4,91 $
EPS
-35,41 $
Beta
0,86
Shares outstanding
2,06 млн
No. of employees
1
Open
5,96 $
High
6,68 $
Low
5,83 $
Mkt. cap
12,05 млн
Avg. vol.
217,08 м.
Volume
43,38 мың
52-wk high
28,75 $
52-wk low
4,91 $
EPS
-35,41 $
Beta
0,86
Shares outstanding
2,06 млн
No. of employees
1
News stories
From web sources and news partners
Investing.com Nigeria
Investing.com Nigeria
·
11 сағат бұрын
Form S-1 GT Biopharma Inc For: 9 October By Investing.com
Stock Traders Daily
Stock Traders Daily
·
1 күн бұрын
Responsive Playbooks and the GTBP Inflection
About GT Biopharma Inc
CEO-
Employees1
Founded1965
HeadquartersСан Франсиско, Калифорния, Америка Құрама Штаттары
Sector-
Analyst ratings
Based on 1 analyst giving stock ratings to GTBP in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for GTBP in the last 3 months
Highest
Current 6,68 $
3,00 $ (-55,09%)
Average
3,00 $ (-55,09%)
Lowest
3,00 $ (-55,09%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jonathan Aschoff
Roth MKM
Buy
Maintained
3,00 $
-55,1%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
634,00 м.
1,38 млн
413,00 м.
1,06 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,75 млн
4,22 млн
2,44 млн
3,46 млн
Operating expense
3,38 млн
5,60 млн
2,85 млн
4,51 млн
Total operating expenses
3,38 млн
5,60 млн
2,85 млн
4,51 млн
Operating income
-3,38 млн
-5,60 млн
-2,85 млн
-4,51 млн
Other non operating income
232,00 м.
-17,33 млн
11,00 мың
-
EBT including unusual items
-3,11 млн
-23,03 млн
-2,83 млн
-4,52 млн
EBT excluding unusual items
-3,11 млн
-23,03 млн
-2,83 млн
-4,52 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,11 млн
-23,03 млн
-2,83 млн
-4,52 млн
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
36,00 мың
17,00 мың
67,00 мың
58,00 мың
Interest expense
-
-127,00 м.
-63,00 мың
-64,00 мың
Net interest expenses
36,00 мың
-110,00 м.
4,00 мың
-6,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары